SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001399529-20-000030
Filing Date
2020-04-22
Accepted
2020-04-22 16:04:13
Documents
5
Period of Report
2020-04-09
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A drna_2020xdef14a.htm DEF 14A 1104804
2 a2019proxytsrtable.jpg GRAPHIC 23712
3 image1a03.gif GRAPHIC 7267
4 voting01.jpg GRAPHIC 404808
5 voting02.jpg GRAPHIC 367831
  Complete submission text file 0001399529-20-000030.txt   2213103
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36281 | Film No.: 20807995
SIC: 2834 Pharmaceutical Preparations